Clinical Trials on Gaucher Disease, Type 1 in Australia
Total 2916 results
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Australasian Gastro-Intestinal Trials GroupCanadian Cancer Trials GroupNot yet recruitingNeuroendocrine TumorsAustralia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, Austria, South Africa
-
Lin BioScience, IncLin BioScience Pty LtdRecruitingRelapsed or Resistant Acute LeukaemiasTaiwan, Australia
-
Bayside HealthUnknownAcute Myeloid LeukemiaAustralia
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bAustralia
-
Peter MacCallum Cancer Centre, AustraliaRecruiting
-
Australasian Gastro-Intestinal Trials GroupAstraZeneca; Wayne Elphinstone Research FundNot yet recruiting
-
Melbourne HealthAnHeart Therapeutics Inc.; Walter and Eliza Hall Institute of Medical ResearchActive, not recruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustralia
-
TakedaRecruitingNarcolepsy Type 1 | Narcolepsy Type 2Spain, Germany, United States, Italy, Netherlands, Japan, France, Norway, Australia, Finland, Switzerland, Sweden
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
-
Grifols Therapeutics LLCEnrolling by invitationPulmonary Emphysema in Alpha-1 Antitrypsin DeficiencyUnited States, New Zealand, Denmark, Australia, Finland, Estonia, Canada, Poland, Russian Federation, Sweden, France
-
Ludwig Institute for Cancer ResearchBristol-Myers SquibbTerminatedMetastatic MelanomaAustralia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Peter MacCallum Cancer Centre, AustraliaCompletedAdenoid Cystic Carcinoma | Colorectal CancerAustralia
-
Bristol-Myers SquibbCompleted
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma (CD20+)Australia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMantle Cell Lymphoma RefractoryAustralia
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2Russian Federation, Spain, Germany, Australia, Austria, Israel, Czech Republic
-
Professor Michael BourkeCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
PfizerViiV HealthcareTerminatedHIV-1South Africa, Australia, United Kingdom, Canada, Italy, Poland, Switzerland, Mexico, Brazil
-
Bayside HealthGilead SciencesUnknown
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, United Kingdom, Canada, Italy, Hungary, Spain, Sweden, Australia, Netherlands, France, Czechia, Finland, Germany, Greece, Ireland, Latvia, Mexico, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, South...
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)Australia, United States
-
Zafgen, Inc.TerminatedObesity | Type 2 DiabetesAustralia
-
PfizerCompletedHIV-1United Kingdom, South Africa, Australia, Canada, Italy, Poland, Switzerland, Argentina, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
Peter MacCallum Cancer Centre, AustraliaRecruitingFollicular LymphomaUnited States, Australia
-
GC Cell CorporationNot yet recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction AdenocarcinomaAustralia
-
SanofiCompleted
-
Baker Heart Research InstituteUnknownObesity | Metabolic Syndrome | Type 2 DiabetesAustralia
-
NuvOx LLCThe AlfredCompletedGlioblastoma MultiformeAustralia
-
IpsenTerminatedNeuroendocrine TumorsUnited States, Australia, Austria, Canada, Denmark, France, Switzerland, United Kingdom
-
Myeloid TherapeuticsRecruitingEpithelial Tumors, MalignantAustralia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Poland, United Kingdom, France, Sweden, Netherlands, Finland, Belgium, Ireland, Germany, Canada, Russian Federation, Australia, Norway, Argentina, Ukraine
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Bayside HealthCompletedObesity | Insulin Resistance | Type 2 DiabetesAustralia
-
Orphatech Pharmaceuticals, GmbHWithdrawnMolybdenum Cofactor Deficiency Type AAustralia
-
Landsteiner InstitutLund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaboratorsCompletedType 2 Diabetes Mellitus | Insulin ResistanceAustria
-
Menzies School of Health ResearchWithdrawn
-
Murdoch Childrens Research InstituteNot yet recruitingHodgkin Lymphoma | Non Hodgkin LymphomaAustralia
-
Astellas Pharma Global Development, Inc.RecruitingB-cell LymphomaAustralia
-
Landsteiner InstitutMedical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaboratorsCompletedType 2 Diabetes MellitusAustria
-
EUROSPK Study GroupWyeth is now a wholly owned subsidiary of Pfizer; Hoffmann-La Roche; Genzyme,... and other collaboratorsCompletedDiabetes Mellitus, Type 1 | Diabetic NephropathyBelgium, Israel, Germany, Austria, Czechia, Spain, Switzerland
-
CSL LimitedCompletedAcute Myeloid Leukemia (AML)Australia